Literature DB >> 18474531

Unintended consequences: mandatory tuberculin skin testing and severe isoniazid hepatotoxicity.

Mark N Lobato1, John A Jereb, Jeffrey R Starke.   

Abstract

After mandatory school-enrollment tuberculin skin testing, a 4-year-old girl who was at low risk for Mycobacterium tuberculosis infection had severe isoniazid hepatotoxicity that was managed with a liver transplant. Although severe isoniazid hepatotoxicity is very uncommon in children, this case emphasizes the need to limit skin testing to persons who have a risk factor for infection and to educate parents on how to monitor for adverse effects during treatment.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18474531     DOI: 10.1542/peds.2007-2773

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  6 in total

1.  Acute liver failure in a pediatric patient with disseminated tuberculosis.

Authors:  Jane Whitney; Melissa Hurwitz; Amirkaveh Mojtahed; Christine Hwang; Amy Gallo
Journal:  Dig Dis Sci       Date:  2011-06-22       Impact factor: 3.199

Review 2.  Advances in Drug Discovery and Development for Pediatric Tuberculosis.

Authors:  Daniel Hoagland; Ying Zhao; Richard E Lee
Journal:  Mini Rev Med Chem       Date:  2016       Impact factor: 3.862

3.  Practices and policies of providers testing school-aged children for tuberculosis, Connecticut, 2008.

Authors:  Christina M Lazar; Lynn Sosa; Mark N Lobato
Journal:  J Community Health       Date:  2010-10

Review 4.  Old and new approaches to diagnosing and treating latent tuberculosis in children in low-incidence countries.

Authors:  Andrea T Cruz; Jeffrey R Starke; Mark N Lobato
Journal:  Curr Opin Pediatr       Date:  2014-02       Impact factor: 2.856

5.  Antituberculosis drug-induced hepatotoxicity in children.

Authors:  Peter R Donald
Journal:  Pediatr Rep       Date:  2011-06-16

6.  Isoniazid-induced severe hepatotoxicity: an infrequent but preventable cause of liver failure in children treated for latent tuberculosis infection.

Authors:  Dan Desrochers; Regino P González-Peralta; Daniel T McClenathan; Michael J Wilsey; Allah Haafiz
Journal:  Clin Med Insights Pediatr       Date:  2011-03-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.